OSR Health faces Nasdaq delisting; trading suspended Aug 26, 2026; appeal planned

OSR Holdings, Inc.

Nasdaq Staff Determination dated Aug 19, 2026: delisting for failure to meet $1.00 minimum bid (Rule 5550(a)(2)).
Trading in OSRH and OSRHW suspended at open on Aug 26, 2026; Form 25-NSE to be filed unless Panel stays.
Company will request Nasdaq Hearings Panel hearing by 4:00 p.m. ET Aug 26, 2026; no stay of suspension.
Aug 17: 370M shares traded (rank #1 on Nasdaq); Aug 18: 145M shares (rank #3), intraday high $0.84.
Public float ~18.5M shares; CEO Peter Hwang cites 'extraordinary conviction' and business fundamentals.

Featured in Daily 8-K Digest

Selected #9 for 2026-08-19. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.